^
Association details:
| Biomarker: | EGFR E709_T710delinsD |
|---|---|
| Cancer: | Non Small Cell Lung Cancer |
| Drug: | erlotinib (EGFR inhibitor) |
| Direction: | Sensitive |
Evidence:
Source:
Title:
EGFR delE709_T710insD: a rare but potentially EGFR inhibitor responsive mutation in non-small-cell lung cancer
Excerpt:
Tumor-derived DNA was genotyped and found to have wild-type KRAS and the EGFR delE709_T710insD exon 18 mutation....The patient was started on erlotinib....Imaging studies following initiation of erlotinib demonstrated significant improvement of the patient's tumor lesions.
DOI:
10.1097/JTO.0b013e3182635ab4
